Browsing Faculty of Medicine by Author "Ramogola-Masire, Doreen"

Now showing items 1-8 of 8

  • Assessing nurses’ adherence to the see-and-treat guidelines of Botswana's national cervical cancer prevention programme 

    Johnson, Lauren G.; Ramogola-Masire, Doreen; Teitelman, Anne M.; Jemmott, John B.; Buttenheim, Alison M. (American Association for Cancer Research, https://www.aacr.org/, 2019-12-18)
    The see-and-treat approach for cervical cancer screening (VIA followed by immediate cryotherapy) was first pilot tested in Botswana in 2009. Botswana’s Ministry of Health and the Botswana-UPenn Partnership collaborated to ...

  • Availability of WHO essential medicines for cancer treatment in Botswana 

    Martei, Yehoda M.; Chiyapo, Sebathu; Ramogola-Masire, Doreen; Dryden-Peterson, Scott M.; Shulman, Lawrence N.; Tapela, Neo (American Society of Clinical Oncology, http://www.asco.org/, 2018-01-23)
    Purpose Stock outs of cancer drugs are potentially fatal but have not been systematically studied in low- and middle-income countries. The aim of this study was to determine the availability and alignment of the Botswana ...

  • Botswana's HIV response: policies, context, and future directions 

    Ramogola-Masire, Doreen; Poku, Ohemaa; Mazhani, Loeto; Ndwapi, Ndwapi; Misra, Supriya; Arscott-Mills, Tonya; Blank, Lilo; Ho-Foster, Ari; Becker, Timothy D.; Yang, Lawrence (Wiley, http://onlinelibrary.wiley.com/, 2020-01-17)
    This brief report describes key periods in the history of the national public health response to the HIV epidemic in Botswana. It reveals the context leading to the development of HIV policies presently in place and current ...

  • Co-infection with HPV types from the same species provides natural cross-protection from progression to cervical cancer 

    Sobota, Rafal S.; Ramogola-Masire, Doreen; Williams, Scott M.; Zetola, Nicola M. (BioMed Central (BMC), http://www.infectagentscancer.com/, 2014-08)
    Background: The worldwide administration of bivalent and quadrivalent HPV vaccines has resulted in cross-protection against non-vaccine HPV types. Infection with multiple HPV types may offer similar cross-protection in the ...

  • Explaining disparities in oncology health systems delays and stage at diagnosis between men and women in Botswana: A cohort study 

    Iyer, Hari S.; Kohler, Racquel E.; Ramogola-Masire, Doreen; Brown, Carolyn; Molebatsi, Kesaobaka; Grover, Surbhi; Kablay, Irene; Bvochora-Nsingo, Memory; Efstathiou, Jason, A.; Lockman, Shahin; Tapela, Neo; Dryden-Peterson, Scott L. (Public Library of Science, http://www.plosone.org/, 2019-06-06)
    Purpose Men in Botswana present with more advanced cancer than women, leading to poorer outcomes. We sought to explain sex-specific differences in time to and stage at treatment initiation. Methods Cancer patients who ...

  • Factors related to advanced stage of cancer presentation in Botswana 

    Anakwenze, Chidinma; Bhatia, Rohini; Rate, William; Bakwenabatsile, Lame; Ngoni, Kebatshabile; Rayne, Sarah; Dhillon, Preet; Narasimhamurthy, Mohan; Ho-Foster, Ari; Ramogola-Masire, Doreen; Grover, Surbhi (American Society of Clinical Oncology, https://beta.asco.org/, 2018-12)
    Purpose: Botswana, a country with a high prevalence of HIV, has an increasing incidence of cancer related mortality in the post–antiretroviral therapy era. Despite universal access to free healthcare, the majority of ...

  • HIV infection and survival among women with cervical cancer 

    Drysen-Peterson, Scott; Bvochora-Nsingo, Memory; Suneja, Gita; Efstathiou, Jason, A.; Grover, Surbhi; Chiyapo, Sebathu; Ramogola-Masire, Doreen; Kebabonye-Pusoentsi, Malebogo; Clayman, Rebecca; Mapes, Abigail, C.; Tapela, Neo; Asmelash, Aida; Medhin, Heluf; Viswanathan, Akila, N.; Russell, Anthony H.; Lin, Lilie, L.; Kayembe, Mukendi K.A.; Mmalane, Mompati; Randall, Thomas C.; Chabner, Bruce; Lockman, Shahin (American Society of Clinical Oncology, https://beta.asco.org/, 2016-08-29)
    Purpose Cervical cancer is the leading cause of cancer death among the 20 million women with HIV worldwide. We sought to determine whether HIV infection affected survival in women with invasive cervical cancer. Patients ...

  • Impact of human immunodeficiency virus infection on survival and acute toxicities from chemoradiation therapy for cervical cancer patients in a limited-resource setting 

    Grover, Surbhi; Yeager, Alyssa; Chiyapo, Sebathu; Bhatia, Rohini; MacDuffie, Emily; Puri, Priya; Balang, Dawn; Ratcliffe, Sarah; Narasimhamurthy, Mohan; Gwangwava, Elliphine; Tsietso, Sylvia; Kayembe, Mukendi K.A.; Ramogola-Masire, Doreen; Dryden-Peterson, Scott; Lin, Lilie L.; Zetola, Nicola M.; Viswanathan, Akila N.; Mahantshetty, Umesh (Elsevier, https://www.elsevier.com/en-xm, 2018-05-01)
    Purpose—To prospectively compare survival between human immunodeficiency virus (HIV)-infected versus HIV-uninfected cervical cancer patients who initiated curative chemoradiation therapy (CRT) in a limited-resource ...